Clopidogrel and Elmiron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Elmiron (pentosan polysulfate sodium). Common drug interactions include retinal pigmentation among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Elmiron. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.

What is Elmiron?

Elmiron has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic). eHealthMe is studying from 10,215 Elmiron users. Check the latest studies of Elmiron.



On Jul, 08, 2026

49 people who take Clopidogrel and Elmiron together, and have interactions are studied.

Clopidogrel and Elmiron drug interactions.

What are the common drug interactions of Clopidogrel and Elmiron, by gender? *:

female:

  1. Retinal pigmentation (pigmentation of retina)
  2. Age-related macular degeneration
  3. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  4. Sinusitis (inflammation of sinus)
  5. Retinal dystrophy (progressive weakness and wasting of the retina)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Infectious mononucleosis (infection usually caused by the epstein-barr virus)
  8. Kidney infection
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Hypersensitivity

male:

  1. Fall
  2. Oedema peripheral (superficial swelling)
  3. Dysuria (painful or difficult urination)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Local swelling (swelling at the site of some application of substance or injury)
  6. Nasopharyngitis (inflammation of the nasopharynx)
  7. Nervousness
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Plasma cell myeloma (cancer that begins in plasma cells)
  10. Pruritus (severe itching of the skin)

What are the common drug interactions of Clopidogrel and Elmiron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Retinal pigmentation (pigmentation of retina)
  2. Age-related macular degeneration
  3. Infusion site discomfort
  4. Nausea (feeling of having an urge to vomit)
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Pneumonia
  7. Seasonal allergy (allergic condition due to certain season)
  8. Thermal burn (burn by heat)
  9. Vomiting
  10. Breast cancer

What are the existing conditions these people have? *

  1. Cystitis Interstitial (unknown cause characterized by bladder pain): 28 people, 57.14%
  2. High Blood Pressure: 19 people, 38.78%
  3. High Blood Cholesterol: 18 people, 36.73%
  4. Pain: 15 people, 30.61%
  5. Depression: 14 people, 28.57%
  6. Urinary Tract Infection: 12 people, 24.49%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 18.37%
  8. Immunodeficiency Common Variable: 7 people, 14.29%
  9. Diabetes: 5 people, 10.20%
  10. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 5 people, 10.20%

* Approximation only. Some reports may have incomplete information.

Do you take Clopidogrel and Elmiron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clopidogrel and Elmiron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clopidogrel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Elmiron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clopidogrel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elmiron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel and pentosan polysulfate sodium (the active ingredients of Clopidogrel and Elmiron, respectively), and Clopidogrel and Elmiron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: